Timothy Eugene Sullivan, Chief Financial Officer at Apellis Pharmaceuticals, Inc. (APLS), bought 23,398 shares at $29.71 ($695K) on 2019-08-29, disclosed to the SEC on 2019-09-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.71 | 11,699 | $348K | 50.0% |
| 2 | $29.71 | 11,699 | $348K | 50.0% |
| Total | $29.71 avg | 23,398 | $695K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $86K | — | Filing → |
| APLS | SELL | 2025-10-23 | $280K | — | Filing → |
| APLS | SELL | 2025-09-10 | $2.1M | — | Filing → |